Tocqueville Asset Management L.P. Forte Biosciences, Inc. Transaction History

Tocqueville Asset Management L.P.

$6.27 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$2.96 - $36.67 $42,920 - $531,715	-14,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$31.5 - $42.5 $63,000 - $85,000	2,000 Added 16.0%	14,500 $487,000
Q1 2021 May 17, 2021	BUY	$25.01 - $40.24 $116,296 - $187,116	4,650 Added 59.24%	12,500 $428,000
Q4 2020 Feb 16, 2021	SELL	$28.66 - $46.79 $4,299 - $7,018	-150 Reduced 1.88%	7,850 $286,000
Q3 2020 Nov 16, 2020	SELL	$14.71 - $50.69 $32,362 - $111,518	-2,200 Reduced 21.57%	8,000 $388,000
Q2 2020 Aug 12, 2020	BUY	$13.9 - $24.6 $141,780 - $250,920	10,200 New	10,200 $149,000

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$3.19 Million
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $371M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.